Design and synthesis of chiral and racemic phosphonate-based haptens for the induction of aldolase catalytic antibodies

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 7, 1997, Pages 1327-1337

  Mu, YongQi ^a   Gibbs, Richard A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC ANTIBODY; FRUCTOSE BISPHOSPHATE ALDOLASE; HAPTEN; PHOSPHONIC ACID DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CHIRALITY; CONTROLLED STUDY; DRUG DESIGN; DRUG MANUFACTURE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INDUCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNIZATION; IN VITRO STUDY; NONHUMAN; PROTEIN PURIFICATION; RABBIT; SERUM; TECHNIQUE;

ANTIBODIES; CATALYSIS; FRUCTOSE-BISPHOSPHATE ALDOLASE; HAPTENS; PHOSPHONIC ACIDS; STEREOISOMERISM;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0030858657     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(97)00088-6     Document Type: Article

References (42)

1. Lerner, R. A.; Benkovic, S. J.; Schultz, P. G. Science 1991, 252, 659.
2. Benkovic, S. J. Annu. Rev. Biochem. 1992, 61, 29.
3. Stewart, J. D.; Benkovic, S. J. Chem. Soc. Rev. 1993, 213.
4. For an example of the synthetic use of a catalytic antibody, see: Sinha, S. C.; Keinan, E. J. Am. Chem. Soc. 1995, 117, 3653.
5. Hilvert, D. Acc. Chem. Res. 1993, 26, 552.
6. Heathcock, C. H. In Asymmetric Synthesis; Morrison, J. D., Ed.; Academic: Orlando, FL, 1984; Vol. 3, pp 111-212.
7. Drueckhammer, D. G.; Hennen, W. J.; Pederson, R. L.; Barbas, C. F.; Gautheron, C. M.; Krach, T.; Wong, C. H. Synthesis 1991, 499.
8. Gijsen, H. J. M.; Wong, C. H. J. Am. Chem. Soc. 1994, 116, 8422.
9. The catalysis of a retro-aldol reaction by an antibody has been recently reported: Flanagan, M. E.; Jacobsen, J. R.; Sweet, E.; Schultz, P. G. J. Am. Chem. Soc. 1996, 118, 6078.
10. Reymond, J.-L.; Chen, Y. Tetrahedron Lett. 1995, 36, 2575.
11. Koch, T.; Reymond, J.-L.; Lerner, R. A. J. Am. Chem. Soc. 1995, 117, 9383.
12. Wagner, J.; Lerner, R. A.; Barbas, C. F. Science 1995, 270, 1797.
13. Diaz, E.; O'Laughlin, J. T.; O'Leary, M. H. Biochemistry 1988, 27, 1336.
14. Bartlett, P. A.; McLaren, K. L.; Marx, M. A. J. Org. Chem. 1994, 59, 2082.
15. Fujii, I.; Lerner, R. A.; Janda, K. D. J. Am. Chem. Soc. 1991, 113, 8528.
16. Liotta, L. J.; Gibbs, R. A.; Taylor, S. D.; Benkovic, P. A.; Benkovic, S. J. J. Am. Chem. Soc. 1995, 117, 4729.
17. Garratt, P. J.; Vollhardt, K. P. C. Synthesis 1971, 423.
18. Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis 2nd edn; John Wiley: New York, 1991.
19. Gravel, D.; Hebert, J.; Thoraval, D. Can. J. Chem. 1983, 67, 400.
20. deGraaf, H. G.; Bickelhaupt, F. Tetrahedron 1975, 31, 1097.
21. Henning, H. G. Z. Chem. 1967, 5, 417.
22. Bhattacharya, A. K.; Thyagarajan, G. Chem. Rev. 1981, 81, 415.
23. (a) Abdel-Meguid, S. S.; Zhao, B.; Murthy, K. H. M.; Winborne, E; Choi, J.-K.; DesJarlais, R. L.; Minnich, M. D.; Culp, J. S.; Debouck, C.; Tomaszek, T. A.; Meek, T. D.; Dreyer, G. B. Biochemistry 1993, 32, 7972.
24. (b) Biller, S. A.; Forster, C. Tetrahedron 1990, 46, 6645.
25. Gray, M. D. M.; Smith, D. J. H. Tetrahedron Lett. 1980, 21, 859.
26. Campbell, D. A. J. Org. Chem. 1992, 57, 6331.
27. Malachowski, W. P.; Coward, J. K. J. Org. Chem. 1994, 59, 7625.
28. (a) Zhao, K.; Landry, D. W. Tetrahedron 1993, 49, 363.
29. (b) Note that we were able to repeat the coupling of cholesterol and 28 as previously reported in ref 27a.
30. Yang, G.; Chun, J.; Arakawa-Uramoto, H.; Wang, X.; Gawinowicz, M. A.; Zhao, K.; Landry, D. W. J. Am. Chem. Soc. 1996, 118, 5881.
31. Lampin, J. P.; Mathey, F.; Bartet, B. Bull. Soc. Chim. Fr. 1971, 317.
32. Nagorski, R. W.; Mizerski, T.; Richard, J. P. J. Am. Chem. Soc. 1995, 117, 4718.
33. McKenna, C. E.; Higa, M. T.; Cheung, N. H.; McKenna, M. Tetrahedron Lett. 1977, 155.
34. (a) Elliot, R. L.; Marks, N.; Berg, M. J.; Portoghese, P. S. J. Med. Chem. 1985, 28, 1208.
35. 1H NMR and reversed-phase HPLC.
36. Corey, E. J.; Link, J. O. Tetrahedron Lett. 1989, 30, 6275.
37. Jones, T. K.; Mohan, J. J.; Xavier, L. C.; Blacklock, T. J.; David, J. M.; Sohar, P.; Jones, E. T. T.; Reamer, R. A.; Roberts, F. E.; Grabowski, E. J. J. Org. Chem. 1991, 56, 763.
38. Gallacher, G.; Jackson, C. S.; Searcey, M.; Badman, G. T.; Goel, R.; Topham, C. M.; Mellor, G. W.; Brocklehurst, K. Biochem. J. 1991, 279, 871.
39. Wilmore, B. H.; Iverson, B. L. J. Am. Chem. Soc. 1994, 776, 2181.
40. Ikeda, S.; Weinhouse, M. I.; Janda, K. D.; Lerner, R. A.; Danishefsky, S. J. J. Am. Chem. Soc. 1991, 113, 7763.
41. 39 it might be of interest to examine their ability to catalyze aldol condensations. It may be of particular interest to examine the ability of serum albumens to catalyze a retro-aldol reaction such as that described by Schultz and co-workers in ref 9.
42. Kikuchi, K.; Thorn, S. N.; Hilvert, D. J. Am. Chem. Soc. 1996, 118, 8184.